Knowthestock.com
AMPH - Amphastar Pharmaceuticals Inc

Hold

Strong Growth but Declining
WeakStrong
WeakStrong

68%

based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 29.26%
Operating Income Growth is -7.97%
Net Income Growth is -8.44%
Earnings Per Share (EPS) Growth is -4.83%
Net Margin is 19.38%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 2.95
Debt Ratio is 0.54
Current Debt to Net Income Ratio is 0.01
Total Debt to Total Assets Ratio is 0.37
Cash Flow is MODERATE
Cash from Operations Growth is -2.64%
Capital Expenditure is High
Net Increase in Cash is Negative
Long Term Score Trend is NEGATIVE
Investment Risk is Low
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Amphastar Pharmaceuticals Inc (AMPH) - http://www.amphastar.com
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
Exchange - NASDAQ
Industry - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector - Professional, Scientific, and Technical Services
CEO - Jack Zhang
Employees - 312
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.